GSTM1 and GSTT1 Allele Frequencies among Various Indian and non-Indian Ethnic Groups

  • Senthilkumar, K.P. (Department of Zoology, The Madura College (Autonomous)) ;
  • Thirumurugan, R. (Department of Zoology, The Madura College (Autonomous))
  • Published : 2012.12.31


Background: Glutathione-S-transferase (GST) is an important phase II xenobiotic compound metabolizing enzyme family, involved in tolerance to a particular drug or susceptibility to a diseasec. This study focused the GSTM1 and T1 null allele frequency in the Gujarat population with a comparison across other Inter- and Intra-Indian ethnic groups to predict variation in the possible susceptible status. Methods: DNA was isolated by a salting out method and GSTM1 and T1 homozygous null genotypes were detected by multiplex polymerase chain reaction in 504 unrelated individuals. The genotype distribution of null alleles was compared with Indian and non Indian ethnics reported earlier in the literature using Fisher's test. Results: The frequencies of the homozygous null genotypes of GSTM1 and GSTT1 were 20% (95%CI 16.7-23.9) and 35.5% (95%CI 31.4-39.9) respectively. GSTM1 null frequency did not deviate from most other Indian ethnic groups but differed from the majority of those of non Indian ethnicity studied. The frequency of homozygous null type of GSTT1 was significantly higher and deviated from all Indian groups and a few of non Indian ethnicity. Conclusions: Gujarat ethnicity, possibly the most susceptible for GSTT1 dependent drug disposition and diseases regarding effects of pollution. Further, the results have implications for GSTT1 dependent drugs used for treatment, a serious problem which needs to be solved by physicians and clinical researchers.


Ethnic variation;GST null genotypes;homozygosity;disease susceptibility;xenobiotics


  1. Reszka E, Wasowicz W, Gromadzinska J (2006). Genetic polymorphism of xenobiotic metabolising enzymes, diet and cancer susceptibility. Brit J Nutr, 96, 609-19.
  2. Rossini A, Rapozo CM, Amorim MF, et al (2002). Frequencies of GSTM1, GSTT1, and GSTP1 polymorphisms in a Brazilian population. Genet Mol Res, 1, 233-40.
  3. Roy B, Dey B, Chakraborty M, Majumder PP (1998). Frequency of homozygous null mutation at the glutathione-s-transferase M1 locus in some populations of Orissa, India. Anthropol Anz, 56, 43-7.
  4. Singh A, Kohli JS (2012). Effect of Pollution on common man in India: a legal perspective. Advances in Life Sci and Technology, 4, 35-41.
  5. Vetriselvi V, Vijayalakshmi K, Solomon FD, Venkatachalam P (2006). Genetic variation of GSTM1, GSTT1 and GSTP1 genes in a South Indian population. Asian Pac J Cancer Prev, 7, 325-8.
  6. Kui H, Robert SS, Robert CM, et al (2006). GSTM1 and GSTT1 polymorphisms, cigarette smoking, and risk of colon cancer: a population-based case-control study in North Carolina (United States). Cancer causes and Control, 17, 385-94.
  7. Kunak SC, Ada AO, Karacaoglan V, et al (2012). Drug/ xenobiotic metabolizing enzyme polymorphisms in a Turkish population. Afr J Pharm Pharacol, 6, 2068-74
  8. Kurose K, Sugiyama E, Saito Y (2012). Population differences in major functional polymorphisms of pharmacokinetics/ pharmacodynamics-related genes in Eastern Asians and Europeans: implications in the clinical trials for novel drug development. Drug Metab Pharmacokinetics, 27, 9-54.
  9. Lacko M, Ophuis MB, Peters HM, Manni JJ (2009). Genetic polymorphisms of smoking-related carcinogen detoxifying enzymes and head and neck cancer susceptibility. Anticancer Res, 29, 753-61.
  10. Lahiri DK, Nurnberger JI (1991). A rapid non-enzymatic method for the preparation of HMW DNA from blood for RFLP studies. Nucl Acids Res, 19, 5444.
  11. Laing RE, Hess P, Shen Y, Wang J, Hu SX (2011). The role and impact of SNPs in pharmacogenomics and personalized medicine. Curr Drug Metab, 12, 460-86.
  12. Lordelo GS, Vilela AL, Akimoto AK, et al (2012). Association between methylene tetrahydrofolate reductase and glutathione S-transferase M1 gene polymorphisms and chronic myeloid leukemia in a Brazilian population. Genet Mol Res, 11, 1013-26.
  13. Magno L AV, Talbot J, Talbot T, et al (2009). Glutathione-Stransferase variants in a Brazilian population. Pharmacology, 83, 231-236.
  14. Masood N, Kayani MA, Malik FA, et al (2011). Genetic variations in carcinogen metabolizing genes associated with oral cancer in Pakistani population. Asian Pac J Cancer Prev, 12, 491-5.
  15. Mishra DK, Kumar A, Srivastava DS, Mittal RD (2004). Allelic variation of GSTT1, GSTM1 and GSTP1 genes in North Indian population. Asian Pac J Cancer Prev, 5, 362-5.
  16. Naveen AT, Adithan C, Padmaja N, et al (2004). Glutathione S-transferase M1 and T1 null genotype distribution in South Indians. Eur J Clin Pharmacol, 60, 403-6.
  17. Nosheen M, Ishrat M, Malik FA, Baig RM, Kayani MA (2010). Association of GSTM1 and GSTT1 gene deletions with risk of head and neck cancer in Pakistan: a case control study. Asian Pac J Cancer Prev, 11, 881-5.
  18. Oke B, Akbas F, Aydin M, Berkkan H (1998). GSTT1 null genotype frequency in a Turkish population. Arch Toxicol, 72, 454-5.
  19. Poste G, Carbone DP, Parkinson DR, et al (2012). Leveling the playing field: bringing development of biomarkers and molecular diagnostics up to the standards for drug development. Clin Cancer Res, 18, 1515-23.
  20. Rebbeck TR (1997). Molecular epidemiology of the human glutathione S-transferase genotypes GSTM1 and GSTT1 in cancer susceptibility. Cancer Epidemiol Biomarkers Prev, 6, 733-43.
  21. Amer MA, Ghattas MH, Abo-ElMatty DM, Abou-El- Ela SH (2011). Influence of glutathione S-transferase polymorphisms on type-2 diabetes mellitus risk. Genet Mol Res, 10, 3722-30.
  22. Anantharaman D, Chaubal PM, Kannan S, Bhisey RA, Mahimkar MB (2007). Susceptibility to oral cancer by genetic polymorphisms at CYP1A1, GSTM1 and GSTT1 loci among Indians: tobacco exposure as a risk modulator. Carcinogenesis, 28, 1455-62.
  23. Andres PL, Skerry LM, Munsat TL, Thornell BJ, Szymonifka J, Schoenfeld DA et al. (2012) Validation of a new strength measurement device for amyotrophic lateral sclerosis clinical trials. Muscle Nerve, 45, 81-5.
  24. Buch S, Kotekar A, Kawle D, Bhisey R (2001). Polymorphisms at CYP and GST gene loci. Prevalence in the Indian population. Eur J Clin Pharmacol, 57, 553-5.
  25. Deisseroth A, Kaminskas E, Grillo J, et al (2012). U.S. food and drug administration approval: ruxolitinib for the treatment of patients with intermediate and high-risk myelofibrosis. Clin Cancer Res, 18, 3212-7.
  26. Ebeshi BU, Bolaji OO, Masimirembwa CM (2011). Glutothione- S-transferase (M1 and T1) polymorphisms in Nigerian populations. J Med Genet Genomics, 3, 56-60.
  27. Habdous M, Herbeth B, Haddy N, et al (2004). Smoking, genetic polymorphisms of glutathione S-transferases and biological indices of inflammation and cellular adhesion in the Stainlas study. Excli, 3, 58-67.
  28. Hamdy SI, Hiratsuka M, Narahara K, et al (2003). Genotype and allele frequencies of TPMT, NAT2, GST, SULT1A1 and MDR-1 in the Egyptian population. Br J Clin Pharmacol, 55, 560-9.
  29. Hirvonen A (1999). Polymorphisms of xenobiotic-metabolizing enzymes and susceptibility to cancer. Environ Hlth Perspect, 107, 37-47.
  30. Jiang Z, Liang K, Zhang Q, Tao L (2012). Glutathione S-transferases polymorphisms confer susceptibility to senile cortical cataract in the Han Chinese population. Mol vis, 18, 1247-52.
  31. Kappert K, Bohm M, Schmieder R, et al (2012). Impact of gender on cardiovascular outcome in patients at cardiovascular high risk: analysis of the telmisartan randomized assessment study in ace-intolerant subjects with cardiovascular disease (transcend) and the ongoing telmisartan alone and in combination with ramipril global endpoint trial (Ontarget). Circulation, doi: 10.1161/CIRCULATIONAHA.111.086660.
  32. Kathuria V (2007). Informal regulation of pollution in a developing country: Evidence from India. Ecol Econ, 63, 403-17.
  33. Konwar R, Manchanda PK, Chaudhary P, et al (2010). Glutathione S-transferase (GST) gene variants and risk of benign prostatic hyperplasia: a report in a North Indian population. Asian Pac J Cancer Prev, 11, 1067-72.

Cited by

  1. GSTP1 Gene Ile105Val Polymorphism Causes an Elevated Risk for Bladder Carcinogenesis in Smokers vol.14, pp.11, 2013,
  2. Clinical, Cytogenetic and CYP1A1 exon-1 Gene Mutation Analysis of Beedi Workers in Vellore Region, Tamil Nadu vol.14, pp.12, 2013,
  3. Leu), GSTM1 (null), and GSTT1 (null) Polymorphisms and Bladder Cancer Risk in a Turkish Population vol.14, pp.6, 2013,
  4. Influence of glutathione S-transferase polymorphisms (GSTT1, GSTM1, GSTP1) on type-2 diabetes mellitus (T2D) risk in an endogamous population from north India vol.40, pp.12, 2013,
  5. Role of Household Exposure, Dietary Habits and Glutathione S-Transferases M1, T1 Polymorphisms in Susceptibility to Lung Cancer among Women in Mizoram India vol.15, pp.7, 2014,
  6. Cancer: Scenario and Relationship of Different Geographical Areas of the Globe with Special Reference to North East-India vol.15, pp.8, 2014,
  7. Risk modulation of GSTM1–GSTT1 interactions to head and neck cancer in tobacco users vol.41, pp.9, 2014,
  8. Genetic polymorphisms of GSTM1, GSTP1 and GSTT1 genes and lung cancer susceptibility in the Bangladeshi population vol.4, pp.12, 2014,
  9. Glutathione S-transferase M1 and T1 null genotype frequency distribution among four tribal populations of western India vol.97, pp.1, 2018,